Proteon Therapeutics Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$1.14 |
Market Cap |
$8.25 M |
Shares Outstanding |
19.59 M |
Public Float |
7.85 M |
Address |
200 West Street Waltham Massachusetts 02451 United States |
Employees | - |
Website | http://www.proteontherapeutics.com |
Updated | 07/08/2019 |
Proteon Therapeutics, Inc. engages in the research and development of biopharmaceutical products. It produces and commercializes vonapanitase for the treatment of renal and vascular disease. The company was founded by F. |